These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 24105103)
1. Bioequivalence studies for 2 different strengths of irbesartan/hydrochlorothiazide combination in healthy volunteers: 300/25 mg and 300/12.5 mg film-coated tablets. Cánovas M; Cabré F; Polonio F Drug Res (Stuttg); 2014 May; 64(5):257-62. PubMed ID: 24105103 [TBL] [Abstract][Full Text] [Related]
2. Bioequivalence study of two oral formulations of irbesartan 300 mg in healthy volunteers. Cánovas M; Cabré F; Polonio F Drug Res (Stuttg); 2014 Jan; 64(1):53-6. PubMed ID: 24048950 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic properties and bioequivalence of two irbesartan/ hydrochlorothiazide fixed-dose combination tablets in healthy male Chinese volunteers. Liu J; Wu L; Hu X; Wu G; Zheng Y; Zhou H; Zhai Y; Zhu M; ShenTu J Int J Clin Pharmacol Ther; 2015 Jul; 53(7):573-81. PubMed ID: 25828636 [TBL] [Abstract][Full Text] [Related]
4. Comparative bioavailability of two irbesartan/hydrochlorothiazide tablet formulations in Indonesian healthy subjects. Sasongko L; Harahap Y; Prasaja B; Lusthom W; Setiawan EC; Meliala RS; Lipin Arzneimittelforschung; 2010; 60(12):749-53. PubMed ID: 21265466 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and bioequivalence study of irbesartan tablets after a single oral dose of 300 mg in healthy Thai volunteers. Wittayalertpanya S; Chariyavilaskul P; Prompila N; Sayankuldilok N; Eiamart W Int J Clin Pharmacol Ther; 2014 May; 52(5):431-6. PubMed ID: 24725445 [TBL] [Abstract][Full Text] [Related]
6. Effect of the combination of lisinopril and hydrochlorothiazide on the bioequivalence of tablet formulations. Koytchev R; Ozalp Y; Erenmemisoglu A; van der Meer MJ; Alpan RS Arzneimittelforschung; 2004 Sep; 54(9A):605-10. PubMed ID: 15497668 [TBL] [Abstract][Full Text] [Related]
7. Combination of losartan and hydrochlorothiazide: in vivo bioequivalence. Koytchev R; Ozalp Y; Erenmemisoglu A; van der Meer MJ; Alpan RS Arzneimittelforschung; 2004 Sep; 54(9A):611-7. PubMed ID: 15497669 [TBL] [Abstract][Full Text] [Related]
8. Bioequivalence study of 2 formulations of film-coated tablets containing a fixed dose combination of bisoprolol fumarate 5 mg and hydrochlorothiazide 6.25 mg in healthy subjects. Tjandrawinata RR; Setiawati E; Yunaidi DA; Santoso ID; Setiawati A; Susanto LW Drug Res (Stuttg); 2013 May; 63(5):243-9. PubMed ID: 23539427 [TBL] [Abstract][Full Text] [Related]
9. Simultaneous determination of irbesartan and hydrochlorothiazide in human plasma using HPLC coupled with tandem mass spectrometry: Application to bioequivalence studies. Tutunji LF; Tutunji MF; Alzoubi MI; Khabbas MH; Arida AI J Pharm Biomed Anal; 2010 Mar; 51(4):985-90. PubMed ID: 20004542 [TBL] [Abstract][Full Text] [Related]
10. Bioequivalence study of two different film-coated tablet formulations of losartan-hydrochlorothiazide in healthy volunteers. Neves R; Almeida S; Filipe A; Spínola AC; Abolfathi Z; Yritia M; Ortuño J Arzneimittelforschung; 2008; 58(8):369-75. PubMed ID: 18807576 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the bioequivalence of two tablet formulations of enalapril/hydrochlorothiazide after single oral administration to healthy volunteers. Niopas I; Daftsios AC; Nikolaidis N Arzneimittelforschung; 2004; 54(3):160-5. PubMed ID: 15112862 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic comparison and bioequivalence evaluation of losartan/ hydrochlorothiazide tablet between Asian Indian and Japanese volunteers. Kumar S; Monif T; Khuroo A; Reyar S; Jain R; Singla AK; Kurachi K Int J Clin Pharmacol Ther; 2014 Jan; 52(1):39-54. PubMed ID: 24290414 [TBL] [Abstract][Full Text] [Related]
13. The relative bioavailability and fasting pharmacokinetics of three formulations of olmesartan medoxomil 20-mg capsules and tablets in healthy Chinese male volunteers: An open-label, randomized-sequence, single-dose, three-way crossover study. Li KY; Liang JP; Hu BQ; Qiu Y; Luo CH; Jiang Y; Lin XP; Yang N Clin Ther; 2010 Aug; 32(9):1674-80. PubMed ID: 20974325 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic properties and bioequivalence of 2 formulations of valsartan 160-mg tablets: A randomized, single-dose, 2-period crossover study in healthy Korean male volunteers. Kim JE; Ki MH; Yoon IS; Cho HJ; Kim RS; Tae Kim G; Kim DD Clin Ther; 2014 Feb; 36(2):273-9. PubMed ID: 24529292 [TBL] [Abstract][Full Text] [Related]
15. Bioequivalence study of two formulations of candesartan cilexetil tablet in healthy subjects under fasting conditions. Tjandrawinata RR; Setiawati E; Yunaidi DA; Simanjuntak R; Santoso ID; Susanto LW Drug Des Devel Ther; 2013; 7():841-7. PubMed ID: 23990709 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and tolerability of olmesartan medoxomil plus hydrochlorothiazide combination in healthy Chinese subjects: drug-drug interaction, bioequivalence, and accumulation. Liu DY; Jiang J; Wang CG; Zhang JY; Hu P Int J Clin Pharmacol Ther; 2014 Apr; 52(4):321-7. PubMed ID: 24472401 [TBL] [Abstract][Full Text] [Related]
17. Bioequivalence studies of film-coated tablet and chewable tablet generic formulations of montelukast in healthy volunteers. Cánovas M; Arcabell M; Martínez G; Canals M; Cabré F Arzneimittelforschung; 2011; 61(11):610-6. PubMed ID: 22232849 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic properties and bioequivalence of olmesartan medoxomil/hydrochlorothiazide in healthy Korean male subjects. Jin C; Jeon JY; Im YJ; Jung JA; Kim Y; Park K; Choi Y; Chae SW; Kim MG Int J Clin Pharmacol Ther; 2014 Jan; 52(1):64-72. PubMed ID: 24290413 [TBL] [Abstract][Full Text] [Related]
19. Bioequivalence study of 2 orodispersible formulations of zolmitriptan 5 mg in healthy volunteers. Cánovas M; Canals M; Polonio F; Cabré F Arzneimittelforschung; 2012 Oct; 62(10):482-6. PubMed ID: 22918855 [TBL] [Abstract][Full Text] [Related]
20. Results of a single-center, single-dose, randomized-sequence, open-label, two-way crossover bioequivalence study of two formulations of valsartan 160-mg tablets in healthy volunteers under fasting conditions. Spínola AC; Almeida S; Filipe A; Neves R; Trabelsi F; Farré A Clin Ther; 2009 Sep; 31(9):1992-2001. PubMed ID: 19843489 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]